Biogen Inc (BIIB)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 28,049,300 28,313,200 26,804,100 26,567,600 26,844,800 28,193,200 25,156,800 24,598,400 24,554,100 24,854,200 25,081,400 23,614,400 23,877,300 23,806,700 24,470,400 23,854,700 24,618,900 24,934,100 25,511,800 26,119,200
Total stockholders’ equity US$ in thousands 16,716,000 16,358,900 15,889,100 15,213,000 14,799,400 14,483,800 14,466,900 13,796,600 13,397,900 12,775,500 11,872,500 11,242,300 10,896,200 10,429,900 10,751,900 10,682,200 10,700,300 10,758,500 11,308,700 12,546,900
Financial leverage ratio 1.68 1.73 1.69 1.75 1.81 1.95 1.74 1.78 1.83 1.95 2.11 2.10 2.19 2.28 2.28 2.23 2.30 2.32 2.26 2.08

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $28,049,300K ÷ $16,716,000K
= 1.68

The financial leverage ratio of Biogen Inc has been gradually declining from 2.08 as of March 31, 2020, to 1.68 as of December 31, 2024. This suggests that the company has been reducing its reliance on debt to finance its operations and investments over this period. A decreasing trend in the financial leverage ratio indicates improved financial stability and lower financial risk for the company. It shows that Biogen Inc has been effectively managing its debt levels and capital structure, which can enhance its overall financial health and resilience in challenging economic conditions. Additionally, a lower financial leverage ratio may also signal greater flexibility for the company in terms of future strategic decisions and expansion opportunities, as it has lower debt obligations to service. Overall, the declining trend in Biogen Inc's financial leverage ratio reflects a positive trajectory in its financial management and risk mitigation strategies.


See also:

Biogen Inc Financial Leverage (Quarterly Data)